MedTrace Logo

Controlled Trial of Chinese Herbal Medicine to Treat Allergic Rhinitis

NCT02027194 · Status: COMPLETED · Phase: PHASE1/PHASE2 · Type: INTERVENTIONAL · Enrollment: 298

Last updated 2015-03-13

No results posted yet for this study

Summary

The aim of this study is to test and compare the effectiveness between three groups - Cure-Allergic Rhinitis Syrup (CS), Yuk ping fung San (YS) and placebo groups - of adolescents (nursing students) with Allergic Rhinitis (AR) in improving their symptoms of AR, body constitution pattern and health-related quality of life.

• The hypothesis are to test the effectiveness of the CS treatment on these students' AR symptoms and quality of life at immediately, one month and two months after completion of the 4-week intervention, when compared with the YS treatment and placebo group.

1. Cure-Allergic Rhinitis Syrup (CS) group will show significantly reduction of AR symptoms over the 2-month follow-up, when compared to those in YS and placebo groups.
2. CS group will indicate a healthier body constitution pattern over the follow-up, when compared to those with YS and placebo group.
3. CS group will indicate significantly greater improvement of their quality of life over 2-month follow-up, when compared to those with YS and placebo group.

Conditions

  • Allergic Rhinitis

Interventions

DRUG

Cure-Allergic Rhinitis Syrup

Delivered one bottle for two weeks to the participants twice

DRUG

Yu-ping-fung San

Delivered one bottle for 2-week usage to the participants twice

DRUG

Placebo

Delivered one bottle (wheat power with favors) for 2-week usage to the participants twice

Sponsors & Collaborators

  • The Hong Kong Polytechnic University

    lead OTHER

Principal Investigators

  • Wai Tong Chien · Professor

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
30 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-06-30
Primary Completion
2014-08-31
Completion
2014-10-31

Countries

  • Hong Kong

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02027194 on ClinicalTrials.gov